Aurobindo Pharma has strengthened its US generics portfolio after its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Everolimus tablets in multiple strengths. The approval covers Everolimus tablets in 0.25 mg, 0.5 mg, 0.75 mg and 1 mg strengths. The product is […]